Insights for Connected, AI-Actionable Life Sciences
Explore the latest ideas shaping life sciences, with expert perspectives on agentic AI, operating system, architecture, contextualized data, and connected operations.
The Clinical Trial Paradox & The Pragmatic Middle Path: Unifying Biological Boldness with Enterprise IT Risk Management
Vasu Rangadass, President and CEO of L7 Informatics, and Ray Veeraraghavan, VP of Science and AI, examine the clinical trial paradox: pharma takes bold biological risks while IT often defaults to familiar, conventional systems. That divide stalls most life science AI initiatives. Their pragmatic middle path adds orchestration over existing systems instead of replacing them,…
Blog Posts.
The Ontology Advantage: Enabling Smarter, Connected Decisions in Life Sciences with L7|ESP®
Life sciences organizations face exponential data growth across research, development, and manufacturing. L7|ESP delivers an ontology-driven platform that unifies fragmented data into a self-learning digital twin—contextualizing information, enabling decision intelligence, and creating continuous feedback loops. Like Palantir transformed defense and finance, L7|ESP brings integrated, actionable intelligence to life sciences organizations.
Closing the Digital Maturity Gap
Marcia Blackmoore explores the widening digital maturity gap in CDMOs and how digital unified platforms address compliance, scalability, and sponsor trust. Featuring insights from Cellipont BioServices and a Contract Pharma webinar, this article shows why digital maturity is now essential for accelerating therapies to patients.
Today’s Best ELN May Not Be Another ELN
Swapping one ELN for another won’t fix silos or deliver sustainable ROI. In this POV, Vasu Rangadass, Ph.D., explains why life sciences companies must stop the cycle of point-solution replacements and embrace a digital unified platform that contextualizes data, orchestrates workflows, and prepares R&D and manufacturing for AI.
Decoding the Platform Hype: A Modern Buyer’s Guide to Digital Life Sciences Platforms
This buyer’s guide to digital life sciences platforms helps organizations cut through vendor hype. Learn how to evaluate claims of “platforms,” compare leading solutions, and identify the features that matter (AI readiness, orchestration, compliance, and contextualized data) so your next investment scales research, manufacturing, and innovation.
Architecture is the Moat: The Hidden Source of AI Advantage in Life Sciences
Life sciences companies are investing heavily in AI, but true advantage doesn’t come from data or algorithms. It comes from architecture; the orchestrated backbone that transforms data into compounding value. This piece explores why architecture is hard to copy and why it’s essential for digital twins, adaptive trials, and personalized medicine.
The Rise of AI Corporate Citizens: Why Life Sciences Organizations Need Data Orchestration, Not Just More Software
AI isn’t a sidekick anymore, it’s like a colleague. But in life sciences, fragmented data often prevents AI from delivering real value. This blog explores how data orchestration enables autonomous agents to thrive as AI corporate citizens, helping organizations move from experimental AI to production-ready, outcome-driven transformation.
Turning Data Into an Engine for Innovation: Why Contextualization and Orchestration Matter More Than Ever in Life Sciences
Life sciences organizations generate vast amounts of data, but 57% report it's not AI-ready due to fragmentation and missing context. Leading companies are achieving measurable ROI by implementing orchestrated, contextualized data platforms that connect every point where data is produced and used.
Top 5 Considerations for Lab Digital Transformation: What Gartner’s Market Convergence Means for Your Data Migration Strategy
Life sciences organizations face complex data migration challenges when modernizing laboratory systems. This article outlines five strategic considerations for digital transformation: platform composability, cross-system orchestration, AI-ready architecture, regulatory compliance, and total cost optimization. Learn how unified platforms enable successful migration from fragmented legacy systems to converged digital operations.
Top 5 Hidden Costs of Delaying Digital Transformation in Life Sciences
Delaying digital transformation comes at a high price for life sciences organizations. This article reveals the top five hidden costs, from lost productivity and rising expenses to missed AI opportunities, compliance risks, and talent drain, supported by leading research. Find out why now is the time to act for a digital future.
Pharma’s Simplification Imperative: From McKinsey’s Vision to Implementation Reality
Pharma’s digital future demands more than strategy; it requires unified data, simplified workflows, and operational orchestration. Explore how industry leaders can move from McKinsey’s vision of simplification to real-world results, leveraging platforms like L7|ESP for lasting competitive advantage.
When Complexity Creeps In: Why Life Sciences Need to Rethink Their Digital Foundation
Life sciences organizations are grappling with fragmented systems and siloed data. In this post, Will Gray explains why digital transformation must start with data contextualization and a solid data foundation, laying the groundwork for scalable operations, AI-readiness, and continuous innovation across research and manufacturing.
Top 5 Questions to Ask When Choosing Lab Digitalization Solutions
Selecting a lab digitalization solution? Here are the top 5 questions every IT leader should ask: covering AI readiness, integration, compliance, flexibility, and cost. Learn how to future-proof your digital lab and maximize ROI, with guidance from L7.